Comparison of the Effect of Allopurinol and Febuxostat on Urinary 2,8-Dihydroxyadenine Excretion and Plasma Levels in Patients with Adenine Phosphoribosyltransferase Deficiency: A Clinical Trial
Latest Information Update: 27 Aug 2024
At a glance
- Drugs Allopurinol (Primary) ; Febuxostat (Primary)
- Indications Inborn genetic disorders
- Focus Therapeutic Use
Most Recent Events
- 27 Aug 2024 New trial record